Decreasing the Engagement Gap for Addiction Treatment in Primary Care

缩小初级保健中成瘾治疗的参与差距

基本信息

项目摘要

Project Summary Significance. Alcohol use disorders (AUDs) are common, costly, and life-threatening, but just 8 in 100 people with a past-year AUD receive treatment. Most individuals with AUDs visit primary care and prefer to receive AUD treatment in primary care. This represents a missed opportunity. Career Development Plan. Dr. Glass is a clinician researcher who has successfully answered important research questions by analyzing complex secondary datasets. His long-term goal is to conduct intervention trials in primary care in order to increase the reach and impact of addiction treatment. The proposed K01 career development award will ensure that he receives the mentoring, training, and research experience needed to achieve this goal. Because new mobile health (mHealth) programs offer a relatively novel—and potentially cost-effective and scalable—approach to increasing the reach of effective AUD treatments into primary care, Dr. Glass will focus his training on data collection and preparing for an effectiveness trial of a promising mHealth intervention for patients with AUDs. This will prepare him to lead rigorous, state-of-the-art trials of AUD interventions in primary care, and ensure he reaches his potential as a leader in AUD research. Research Plan. Dr. Glass's proposed research will evaluate the feasibility and acceptability of an existing mHealth tool (Square2) as a new option for managing AUDs in primary care. The Square2 program includes several evidence-based electronic tools for addiction treatment and associated comorbidity (depression, anxiety and tobacco use), and is designed to address the needs of primary care patients irrespective of their AUD severity or readiness to change. However, Square2 has not yet been empirically tested in primary care or for AUD treatment, and developmental research is needed to identify the optimal approach to engaging a generalizable primary care sample of patients with AUDs in a trial of Square2. Specific aims for the proposed K01 are: (Aim 1) Assess the needs of primary care patients with AUDs, and clinicians who care for them, for use of mHealth as part of primary care management of AUDs (n = 40); and (Aim 2) Pilot a randomized controlled trial (RCT) to inform a future effectiveness trial by assessing a) the feasibility and acceptability of delivering Square2 in primary care with clinician assistance, and b) the feasibility of the RCT design (n = 60). Mentorship and Environment. Expert investigators in AUDs in primary care (Primary Mentor Dr. Bradley); mHealth (Co-Mentors Drs. Marsch and McClure); data collection (Co-Mentor Dr. Curran); and pragmatic trials (advisor Dr. Simon) will support this research. The research will be conducted at the Group Health Research Institute, an innovative research institution embedded in a large primary care system in the Pacific Northwest. Public Health Impact: The proposed activities will ensure the development of Dr. Glass into an innovative independent researcher. Moreover, the proposed research will lay the groundwork for future R01s of mHealth tools to increase the reach of effective AUD treatments, thereby improving outcomes for patients with AUDs.
项目总结

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Receipt of evidence-based alcohol-related care in a national sample of transgender patients with unhealthy alcohol use: Overall and relative to non-transgender patients.
  • DOI:
    10.1016/j.jsat.2021.108565
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Williams EC;Chen JA;Frost MC;Rubinsky AD;Edmonds AT;Glass JE;Lehavot K;Matson TE;Wheat CL;Coggeshall S;Blosnich JR
  • 通讯作者:
    Blosnich JR
Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial).
  • DOI:
    10.1186/s13012-022-01258-9
  • 发表时间:
    2023-02-01
  • 期刊:
  • 影响因子:
    7.2
  • 作者:
    Glass, Joseph E.;Dorsey, Caitlin N.;Beatty, Tara;Bobb, Jennifer F.;Wong, Edwin S.;Palazzo, Lorella;King, Deborah;Mogk, Jessica;Stefanik-Guizlo, Kelsey;Idu, Abisola;Key, Dustin;Fortney, John C.;Thomas, Rosemarie;McWethy, Angela Garza;Caldeiro, Ryan M.;Bradley, Katharine A.
  • 通讯作者:
    Bradley, Katharine A.
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study.
  • DOI:
    10.1186/s13722-023-00387-w
  • 发表时间:
    2023-05-08
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Mogk, Jessica M. M.;Matson, Theresa E. E.;Caldeiro, Ryan M. M.;Mcwethy, Angela M. Garza M.;Beatty, Tara;Sevey, Brandie C. C.;Hsu, Clarissa W. W.;Glass, Joseph E. E.
  • 通讯作者:
    Glass, Joseph E. E.
Disparities in Documented Drug Use Disorders Between Transgender and Cisgender U.S. Veterans Health Administration Patients.
  • DOI:
    10.1097/adm.0000000000000769
  • 发表时间:
    2021-07-01
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Frost MC;Blosnich JR;Lehavot K;Chen JA;Rubinsky AD;Glass JE;Williams EC
  • 通讯作者:
    Williams EC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Edwin Glass其他文献

Joseph Edwin Glass的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Edwin Glass', 18)}}的其他基金

C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
  • 批准号:
    10493961
  • 财政年份:
    2022
  • 资助金额:
    $ 18.1万
  • 项目类别:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
酒精质量的多层次影响和结果测量
  • 批准号:
    10590820
  • 财政年份:
    2022
  • 资助金额:
    $ 18.1万
  • 项目类别:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
酒精质量的多层次影响和结果测量
  • 批准号:
    10704144
  • 财政年份:
    2022
  • 资助金额:
    $ 18.1万
  • 项目类别:
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
  • 批准号:
    10668496
  • 财政年份:
    2022
  • 资助金额:
    $ 18.1万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    10092143
  • 财政年份:
    2019
  • 资助金额:
    $ 18.1万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    10349443
  • 财政年份:
    2019
  • 资助金额:
    $ 18.1万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    9902391
  • 财政年份:
    2019
  • 资助金额:
    $ 18.1万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    10560538
  • 财政年份:
    2019
  • 资助金额:
    $ 18.1万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字化治疗:干预措施适应的观察分析
  • 批准号:
    10652751
  • 财政年份:
    2019
  • 资助金额:
    $ 18.1万
  • 项目类别:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
缩小初级保健中成瘾治疗的参与差距
  • 批准号:
    9981556
  • 财政年份:
    2017
  • 资助金额:
    $ 18.1万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 18.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了